The therapeutic activity of IFN-γ against TB and MDR-TB has been intensively studied since the end of the last century; a number of clinical studies have demonstrated the effectiveness of IFN-γ against TB, including MDR-TB [43-49]. Here, IFNG is linked to tuberculosis.